Elevance Health (ELV) Stock Forecast & Price Target

$413.41 -8.27 (-1.96%)

Closing price 03:59 PM Eastern

Extended Trading

$415.41 +2.00 (+0.48%)

As of 07:56 PM Eastern

Elevance Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
0

Hold
4

Buy
13

Based on 17 Wall Street analysts who have issued ratings for Elevance Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 4 have given a hold rating, and 13 have given a buy rating for ELV.

Consensus Price Target

$509.44
23.23% Upside

According to the 17 analysts' twelve-month price targets for Elevance Health, the average price target is $509.44. The highest price target for ELV is $631.00, while the lowest price target for ELV is $440.00. The average price target represents a forecasted upside of 23.23% from the current price of $413.41.

Get the Latest News and Ratings for ELV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Elevance Health and its competitors.

ELV Analyst Ratings Over Time

Type	Current Forecast 4/28/24 to 4/28/25	1 Month Ago 3/29/24 to 3/29/25	3 Months Ago 1/29/24 to 1/28/25	1 Year Ago 4/29/23 to 4/28/24
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)
Hold	4 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$509.44	$519.81	$524.47	$587.42
Forecasted Upside	23.23% Upside	20.37% Upside	29.28% Upside	9.34% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ELV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ELV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Elevance Health Stock vs. The Competition

Type	Elevance Health	Medical Companies	S&P 500
Consensus Rating Score	2.76	2.82	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	21.49% Upside	2,984.87% Upside	21.38% Upside
News Sentiment Rating	Positive News See Recent ELV News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/23/2025	Royal Bank of Canada 4 of 5 stars	Ben Hendrix Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$478.00 ➝ $478.00	+11.41%
4/23/2025	Guggenheim 2 of 5 stars	J. Cassorla Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$518.00 ➝ $518.00	+20.37%
4/23/2025	Cantor Fitzgerald 3 of 5 stars	Sarah James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$485.00 ➝ $485.00	+12.63%
4/23/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$512.00 ➝ $522.00	+25.46%
4/15/2025	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/15/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Neutral	$625.00 ➝ $529.00	+19.95%
4/11/2025	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$480.00 ➝ $510.00	+16.95%
4/9/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$455.00 ➝ $505.00	+17.31%
3/28/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform
3/17/2025	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$450.00	+6.71%
Get the Latest News and Ratings for ELV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.
1/28/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$483.00 ➝ $478.00	+16.26%
1/22/2025	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Fidel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$520.00 ➝ $440.00	+12.98%
10/23/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$643.00 ➝ $551.00	+31.24%
10/21/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$589.00 ➝ $484.00	+12.56%
10/18/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$485.00	+12.18%
10/18/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$605.00 ➝ $555.00	+28.06%
7/18/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Neutral	$646.00 ➝ $530.00	+1.89%
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$628.00 ➝ $631.00	+24.00%
4/19/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$602.00 ➝ $604.00	+15.01%
7/12/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:16 PM ET.

ELV Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Elevance Health is $509.44, with a high forecast of $631.00 and a low forecast of $440.00.
: 17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Elevance Health in the last year. There are currently 4 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ELV shares.
: According to analysts, Elevance Health's stock has a predicted upside of 23.23% based on their 12-month stock forecasts.
: Over the previous 90 days, Elevance Health's stock had 1 upgrade and 1 downgrade by analysts.
: Elevance Health has been rated by research analysts at Argus, Baird R W, Barclays, Cantor Fitzgerald, Guggenheim, Mizuho, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like Elevance Health less than other "medical" companies. The consensus rating score for Elevance Health is 2.76 while the average consensus rating score for "medical" companies is 2.82. Learn more on how ELV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:ELV) was last updated on 4/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elevance Health (ELV) Stock Forecast & Price Target